Resolution Chemicals Ltd v H. Lundbeck A/S: SPCs and privity

No items found.
​
April 18, 2013
No items found.
Table of contents
  • Toc Heading
  • Toc Heading

Darren Smyth’s latest IPKat post concerns the recent decision on a preliminary point in Resolution Chemicals Ltd v H. Lundbeck A/S, and Lundbeck’s SPC for escitalopram.

The case was an action for revocation of Lundbeck’s SPC for invalidity of the underlying patent, and the judgement mainly concerned whether Resolution was estopped from bringing the action by privity of interest with the claimants in an earlier case relating to the same SPC.

Related articles

See all articles

Swarovski’s marksman hits the right target – why Leica should define the correct problem to be solved
18 June 2013
Swarovski-Optik KG v Leica Camera AG [2013] EWHC 1227.SummaryAt the Patents Court before Vos J, Swarovski-Optik brought patent infringement proceedings against Leica Camera, who challenged the...
​
When is an embryo an embryo?
29 May 2013
Despite recent guidance, the UK High Court has deemed it necessary to refer a question to the Court of Justice of the European Union (CJEU) that seeks to clarify what is meant by a “human embryo”,...
​
Resolution Chemicals Ltd v H. Lundbeck A/S: SPCs and privity
18 April 2013
Darren Smyth’s latest IPKat post concerns the recent decision on a preliminary point in Resolution Chemicals Ltd v H. Lundbeck A/S, and Lundbeck’s SPC for escitalopram.
​